Current stock page

Stock Analysis

Kodiak Sciences Inc. (KOD) Stock Analysis

Kodiak Sciences Inc. (KOD) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

KOD Stock Analysis Summary

Kodiak Sciences Inc. (KOD) currently has an AIQ Score of 52/100, indicating a neutral setup. Momentum is the strongest factor at 91/100. Quality is the weakest current factor at 9/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

KOD at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$111.19
AIQ Score52/100
Overall ViewNeutral
Technical Analysis ConsensusStrong Buy
Market Cap$7B
P/E Ratio (TTM)-27.25
Forward P/E—
EPS (Q3 FY2026)-$1.05
Revenue (Q3 FY2026)$0
Dividend Yield (TTM)0.00%
Beta0.15
Volume972.26K
52-week range$18.05-$112.79
RSI 1468.87
50-Day SMA$76.72
200-Day SMA$45.93
Analyst Price Target$115.25
Next Earnings—
As of Nov 13, 2026 · Market close

KODKodiak Sciences Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$111.19+$2.94 (+2.72%)

Latest quote

  • Momentum
    91
  • Value
    —
  • Quality
    9
  • Risk resilience
    44
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

KOD Stock Analysis Summary

Kodiak Sciences Inc. (KOD) currently has an AIQ Score of 52/100, indicating a neutral setup. Momentum is the strongest factor at 91/100. Quality is the weakest current factor at 9/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Neutral

In a neutral regime, KOD has AIQ Score of 52/100 with Momentum base of 91/100 and fading Quality at 9/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (91/100) leads while Quality (9/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 2.72% stock move · KOD classified in Biotechnology.

Current Evidence

NeutralKOD is in a neutral AIQ regime; Momentum is the strongest visible factor at 91/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is KOD Bullish or Bearish Right Now?

KOD currently has a neutral overall setup. Momentum is the strongest factor at 91/100, while Quality is weakest at 9/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Momentum is constructive at 91/100.
  • - Price is +44.93% above its 50-day SMA.
  • - Analyst target implies +3.65% upside from the latest quote.
  • - Technical consensus has more buy votes than sell votes (37 vs 6).
Bear Case
  • - Risk Resilience is weak at 44/100.

Current Consensus

KOD's Technical Analysis Consensus is currently Strong Buy, with 37 buy, 3 neutral, and 6 sell votes. KOD's 14-day RSI is 68.87, which places the stock in a constructive momentum range. KOD's beta is 0.15, indicating lower market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in KOD?

The largest recent change in KOD is Quality moving down by 6.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
-1.0
Momentum
+3.0
Quality
-6.0
Risk
+1.0

What Would Change the KOD Outlook?

The current neutral outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

KOD Decision Framework

Public evidence layers, setup checks, and risk context for Kodiak Sciences Inc..

Kodiak Sciences Inc. (KOD) Stock Analysis

Kodiak Sciences Inc. has an AIQ Score of 52/100 in a Neutral regime. Momentum is strongest at 91/100. Beta is 0.15, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextKOD is in a Neutral AIQ regime with score 52/100.
Signal ConflictThe primary conflict is that momentum leads at 91/100 while quality lags at 9/100.
Factor EvidenceMomentum 91/100 · Quality 9/100 · Risk 44/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 91/100.

TimingPass

Momentum is 91/100 and RSI (14) is 68.9.

Regime fitWait

KOD is in a Neutral regime at 52/100.

Risk controlFail

Risk factor is 44/100 with beta 0.15 and annual volatility 205.61%.

ConflictWait

Current conflict: momentum leads at 91/100 while quality lags at 9/100.

AIQ Score
52/100
Price
$111.19
Beta
0.15
RSI (14)
68.9

KOD Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

KOD Fundamentals

KOD valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$0
Net income
-$66.22M
Free cash flow
-$45.85M
View full KOD fundamental analysis

KOD Technical Analysis

KOD technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
68.87
Price vs SMA-50
+44.93%
View full KOD technical analysis

KOD Stock Catalysts

Track KOD earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
—
Analyst target
$115.25
News items
5
View KOD earnings and stock catalysts

KOD Dividend Analysis

KOD dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View KOD dividend history and analysis

KOD Financial Data

KOD revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$0
EPS
-$1.05
Periods
8
View KOD financials

KOD Risk Analysis

KOD volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.15
Risk score
44/100
1Y volatility
205.61%
View KOD risk analysis

KOD Stock News

KOD stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 15, 2026
Sentiment
—
Read KOD stock news

KOD vs Biotechnology Peers

Current peer cohort: KOD · KRYS · KURA · KYMR · LGND. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
KOD
Current stock
52/100—91/10044/1001.43205.61%Current
KRYS
Krystal Biotech, Inc.
69/10067/10058/10069/1001.1639.38%KOD vs KRYS
KURA
Kura Oncology, Inc.
47/10070/10040/10039/100-0.2563.01%KOD vs KURA
KYMR
Kymera Therapeutics, Inc.
65/10043/10087/10060/1001.3363.12%KOD vs KYMR
LGND
Ligand Pharmaceuticals Incorporated
76/10061/10086/10070/1001.2536.55%KOD vs LGND
Pairwise Compare links: KRYS · KURA · KYMR · LGNDKOD vs KRYSKOD vs KURAKOD vs KYMRKOD vs LGNDCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a KOD stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for KOD: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-27.25
As of Nov 13, 2026
Revenue growth
—
Gross margin
0.00%
Current debt / equity
3.7
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$0
Quarter net income
-$66.22M
Quarter free cash flow
-$45.85M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Bullish
RSI 14
68.87
MACD
8.12

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
44/100
Beta
0.15
Annual volatility
205.61%
Max drawdown
-36.24%

KOD Stock FAQ

What is KOD stock price today?

Kodiak Sciences Inc.'s current stock price is $111.19. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is KOD bullish or bearish right now?

KOD's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is KOD's market cap?

KOD's market cap is $7B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is KOD's current P/E ratio?

KOD's current P/E ratio is -27.25 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is KOD's RSI?

KOD's 14-day RSI is 68.87 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is KOD above its 50-day and 200-day moving averages?

KOD is 44.93% from its 50-day SMA and 142.11% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is KOD's next earnings date?

KOD's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does KOD pay a dividend?

KOD's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.